Aurobindo Irbesartan Class Action Settlements — 2 Active Cases
SettlementRadar is not affiliated with, endorsed by, or connected to Aurobindo Irbesartan. This page provides independent information about class action settlements involving this company.
0 no-proof settlements — file with no documentation required. Deadlines are approaching. Check eligibility now.
Open Aurobindo Irbesartan Settlements
Aurobindo Irbesartan Class Action Settlement -- $2 Million for Contaminated Blood Pressure Drug
Aurobindo Pharma agreed to a $2,000,000 class action settlement for consumers who purchased Aurobindo irbesartan blood pressure drugs allegedly contaminated with NDEA, a probable human carcinogen. Class period: January 1, 2016 to present. Claim deadline June 2, 2026. Final approval hearing June 30, 2026.
Aurobindo Irbesartan $2M Drug Contamination Settlement
Consumers who purchased Aurobindo Irbesartan since 2016 may be eligible to claim a cash payment from a class action settlement.